Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Return on Sales (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Return on Sales for 13 consecutive years, with 1.49% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales fell 104.0% to 1.49% in Q4 2025 year-over-year; TTM through Dec 2025 was 1.07%, a 47.0% decrease, with the full-year FY2025 number at 1.07%, down 47.0% from a year prior.
  • Return on Sales was 1.49% for Q4 2025 at Ekso Bionics Holdings, down from 0.34% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.34% in Q3 2025 to a low of 1.96% in Q2 2025.
  • A 5-year average of 1.09% and a median of 1.01% in 2025 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: surged 164bps in 2021, then tumbled -148bps in 2025.
  • Ekso Bionics Holdings' Return on Sales stood at 1.94% in 2021, then surged by 35bps to 1.27% in 2022, then skyrocketed by 43bps to 0.73% in 2023, then surged by 38bps to 0.45% in 2024, then plummeted by -230bps to 1.49% in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Return on Sales are 1.49% (Q4 2025), 0.34% (Q3 2025), and 1.96% (Q2 2025).